Microdystrophin gene therapy constructs and uses thereof
TW202635888APending Publication Date: 2026-09-01REGENXBIO INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114146242
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-05-14
- Filing Date
- 2020-11-27
- Publication Date
- 2026-09-01
Smart Images

Figure TWG2TA001074757_001 
Figure TWG2TA001074757_002 
Figure TWG2TA001074757_003
Abstract
Provided is an invention based, in part, on novel gene constructs that encode a microdystrophin protein for use in gene therapy. The microdystrophin gene constructs and expression cassettes were engineered for improved therapy with respect to efficacy, potency and safety to the subject when expressed by a viral vector in muscle cells and / or CNS cells.
Need to check novelty before this filing date? Find Prior Art